INSR and Parkinson disease: Given the involvement of insulin receptor signaling and TLR4 in PD pathology, the present study evaluated the effect of modulation of these pathways using insulin, S961, and TAK242 on motor performance in a rat model of PD induced by 6-hydroxydopamine (6-OHDA).